Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Shares Outstanding (Weighted Average) (2016 - 2026)

Aytu Biopharma has reported Shares Outstanding (Weighted Average) over the past 15 years, most recently at $12.6 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 107.04% to $12.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.6 million through Dec 2025, up 107.04% year-over-year, with the annual reading at $6.3 million for FY2025, 13.39% up from the prior year.
  • Shares Outstanding (Weighted Average) was $12.6 million for Q4 2025 at Aytu Biopharma, up from $9.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $12.6 million in Q4 2025 and troughed at $15571.0 in Q2 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $3.8 million (2024), against an average of $4.1 million.
  • Year-over-year, Shares Outstanding (Weighted Average) crashed 99.8% in 2021 and then skyrocketed 6947.17% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 million in 2021, then increased by 28.63% to $1.7 million in 2022, then soared by 223.77% to $5.5 million in 2023, then rose by 10.91% to $6.1 million in 2024, then surged by 107.04% to $12.6 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Shares Outstanding (Weighted Average) are $12.6 million (Q4 2025), $9.4 million (Q3 2025), and $15571.0 (Q2 2025).